weak magnetic fields against pain in fibromyalgia

Phase 2

Withdrawn

• Conditions: weak parts reuma; medisch onbegrepen klachten; 10077546

• Registration Number: NL-OMON41810
• Lead Sponsor: niversitair Medisch Centrum Groningen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Not specified
• Target Recruitment: 30

Inclusion Criteria

fibromyalgia
pain

Exclusion Criteria

severe psychiatric illness
neurological disorder
change in medication/ongoing therapy during study and 4 weeks before

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Cerebral functioning (fMRI) t rest and during a movement task</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Visual Analoge Scale for pain (0-10), change in score between baseline (week 0)<br /><br>and endpoint (week 5) and Fibromyalgie Score (FS) (sum WPI and SS, see<br /><br>protocol, and psychological well-being (questionnaires)</p><br>